Mavefar SRL
The score of Mavefar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -21 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mavefar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 04 Jun 2025
- Year ended 31 Dec 2023filed on 13 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Mavefar's financial analysis
- Solvency35.7%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mavefar
Mavefar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0867.317.778
- VAT number
- BE0867317778
- Peppol
- Registered · 0208:0867317778 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2004
- Registered office
- 4530 Villers-le-Bouillet
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mavefar (SRL) has been based in Villers-le-Bouillet since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 37,691 € and equity of 432,135 €; its revenue is not published. Its solvency stands at 35.7%, below the median of its sector (40.1%).
Companies similar to Mavefar
Companies in the same business, of comparable size and area, outside its group.
- ANAP Retail sale of pharmaceutical products Aalst · balance sheet €1.37m
- SYJA Retail sale of pharmaceutical products As · balance sheet €1.30m
- Apotheek Bultynck Retail sale of pharmaceutical products Ostend · balance sheet €1.40m
- Pharmacie DE LA Drêve Retail sale of pharmaceutical products Seneffe · balance sheet €1.74m
- Thomas Broos Retail sale of pharmaceutical products Herent · balance sheet €1.19m
- Pharmanaus Retail sale of pharmaceutical products Herve · balance sheet €1.18m
- Dorothee Retail sale of pharmaceutical products Uccle · balance sheet 990,089 €
- Rozental & Herman Retail sale of pharmaceutical products Charleroi · balance sheet €1.05m
Frequently asked questions about Mavefar
What is the revenue of Mavefar?
Mavefar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mavefar?
In Belgium, the VAT number is the company number prefixed with BE: BE0867317778 for Mavefar, if the company is VAT-registered. Its company number (CBE) is 0867.317.778.
Where is the registered office of Mavefar?
According to the CBE register, the registered office of Mavefar is in 4530 Villers-le-Bouillet.
What is the equity of Mavefar?
At the close of the 2025 financial year, the equity of Mavefar amounts to 432,135 €, a solvency of 35.7% of total assets.
Who manages Mavefar?
The register lists 1 active mandates at Mavefar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mavefar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →